Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Colchicine in Patients With Heart Failure and Preserved Left Ventricular Ejection Fraction

NCT05637398 is registered in ClinicalTrials.gov with I.M. Sechenov First Moscow State Medical University as lead sponsor.

NCT NCT05637398
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05637398 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Colchicine in Patients With Heart Failure and Preserved Left Ventricular Ejection Fraction
Lead sponsor
I.M. Sechenov First Moscow State Medical University
Phase
Phase 1/2
Overall status
Completed
Start date
December 15, 2022
Completion date
September 1, 2025
Enrollment
42 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

colchicine, hfpef - heart failure with preserved ejection fraction